Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-11-08

Clinical Trial Update: Presep and Vascath Interaction Study

View source ↗

Summary

The clinical trial evaluating the interaction between Presep and Vascath in patients undergoing hemodynamics and renal dialysis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Presep
  • Vascath

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Hemodynamics, Renal Dialysis | Status: WITHDRAWN